Trials / Completed
CompletedNCT00542607
Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
Trial to Compare the Efficacy and Safety of Levocetirizine 5 mg od and Fexofenadine 120 mg od in Reducing Symptoms of Seasonal Allergic Rhinitis in Grass Pollen Sensitized Adults
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
No information was yet available over the effect of levocetirizine in children under 12 years. The aim of this double-blind, placebo-controlled study was to assess the efficacy and safety of levocetirizine in children from 6 to 12 years old with perennial allergic rhinitis due to house dust mites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levocetirizine dihydrochloride |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2002-12-01
- Completion
- 2002-12-01
- First posted
- 2007-10-11
- Last updated
- 2013-12-12
Source: ClinicalTrials.gov record NCT00542607. Inclusion in this directory is not an endorsement.